Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$7.35 - $13.21 $86,105 - $154,755
-11,715 Reduced 43.39%
15,285 $112,000
Q1 2023

Apr 13, 2023

BUY
$7.79 - $16.29 $12,876 - $26,927
1,653 Added 6.52%
27,000 $279,000
Q4 2022

Jan 18, 2023

BUY
$11.0 - $21.45 $10,054 - $19,605
914 Added 3.74%
25,347 $0
Q3 2022

Oct 20, 2022

BUY
$20.09 - $35.8 $200,036 - $356,460
9,957 Added 68.78%
24,433 $513,000
Q1 2022

May 04, 2022

BUY
$36.48 - $52.22 $24,149 - $34,569
662 Added 4.79%
14,476 $594,000
Q3 2021

Oct 20, 2021

BUY
$50.07 - $66.05 $691,666 - $912,414
13,814 New
13,814 $692,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Summer Haven Investment Management, LLC Portfolio

Follow Summer Haven Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Haven Investment Management, LLC with notifications on news.